Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Sep 8;22(1):40–54. doi: 10.22074/cellj.2020.6550

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

The Cell Journal (Yakhteh) is an open access journal which means the articles are freely available online for any individual author to download and use the providing address. The journal is licensed under a Creative Commons Attribution-Non Commercial 3.0 Unported License which allows the author(s) to hold the copyright without restrictions that is permitting unrestricted use, distribution, and reproduction in any medium provided the original work is properly cited.

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Fig.5 — Effect of plasma-derived exosome of DLBCL patients on proliferation of labeled NK cell with CFSE. A. CFSE-positive NK cell population of a representative responsive DLBCL patient was cultured in the absence or presence of plasma-derived exosome from DLBCL patients, for three days. The dotted blue line represents unstained NK cells. Gray line with an empty profile in histograms indicates unstimulated CFSE-labeled NK cells and B. Degree of significance in the treated NK cells with plasma-derived exosomes of responsive or refractory/relapsed patients with DLBCL compared to the untreated NK cells, is indicated by *P=0.05, **P=0.01, and ***P=0.001 in each group. Each column illustrates the mean SE for proliferation rate of NK cells. DLBCL; Diffuse large B-cell lymphoma and NK; Natural killer cells.